{"665779":{"#nid":"665779","#data":{"type":"event","title":"Hard Tech Venture Capital","body":[{"value":"\u003Cp\u003ELearn how venture capitalists decide to invest with hard-tech, medical devices, and diagnostic\u0026nbsp;seed funds for SOSV Ventures.\u003C\/p\u003E\r\n\r\n\u003Cp\u003E\u003Cstrong\u003E\u003Ca href=\u0022https:\/\/hax.co\/team\/andrew-gollach\u0022\u003EAndrew Gollach, MBA\u003C\/a\u003E\u003Cbr \/\u003E\r\nPrincipal\u003Cbr \/\u003E\r\nHAX, Hard Tech Venture Capital\u003C\/strong\u003E\u003C\/p\u003E\r\n\r\n\u003Cp\u003ELunch provided.\u003C\/p\u003E\r\n","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":"","field_summary_sentence":[{"value":"Andrew Gollach, MBA, Principal at HAX\/SOSV"}],"uid":"35486","created_gmt":"2023-02-14 15:00:18","changed_gmt":"2023-02-14 15:54:05","author":"Christina Wessels","boilerplate_text":"","field_publication":"","field_article_url":"","field_event_time":{"event_time_start":"2023-02-16T11:00:00-05:00","event_time_end":"2023-02-16T12:00:00-05:00","event_time_end_last":"2023-02-16T12:00:00-05:00","gmt_time_start":"2023-02-16 16:00:00","gmt_time_end":"2023-02-16 17:00:00","gmt_time_end_last":"2023-02-16 17:00:00","rrule":null,"timezone":"America\/New_York"},"extras":[],"groups":[{"id":"655285","name":"GT Commercialization"},{"id":"1292","name":"Parker H. Petit Institute for Bioengineering and Bioscience (IBB)"}],"categories":[],"keywords":[{"id":"188880","name":"go-bio-commercialization"},{"id":"187423","name":"go-bio"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[{"id":"1795","name":"Seminar\/Lecture\/Colloquium"}],"invited_audience":[{"id":"78761","name":"Faculty\/Staff"},{"id":"177814","name":"Postdoc"},{"id":"78771","name":"Public"},{"id":"174045","name":"Graduate students"},{"id":"78751","name":"Undergraduate students"}],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[],"email":[],"slides":[],"orientation":[],"userdata":""}}}